This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Accelr8 Announces Results In Award-Winning Presentation For Rapid Diagnostics With ICU Specimens

Accelr8 Technology Corporation (NYSE Amex: AXK) announced results presented at the 51 st ICAAC held in Chicago on September 17. As previously announced in July, the presenters received an award for an “outstanding presentation of an abstract accepted by ICAAC.” The presentation title is “Same-Shift ID Directly from Respiratory Specimens by Automated Microscopy.” It reported results from a study using Accelr8’s BACcel™ rapid diagnostic system in collaboration with investigators at the Barnes-Jewish Hospital in St. Louis.

The study reported results with 53 bacteria-positive lung specimens from ICU patients. Of these, 16 were positive for the two most common ICU pathogens that can express multi-drug resistance (MDR)— Staphylococcus aureus (the common “Staph”) and Pseudomonas aeruginosa. The latter Gram-negative organism is one of the most complex and difficult to treat MDR threats found in hospital-acquired infections.

Accelr8’s BACcel™ rapid diagnostic system correctly identified 9/9 S. aureus and 7/7 P. aeruginosa directly from specimen samples. It also correctly identified the lack of these target organisms in the remaining 37 specimens, yielding detection sensitivity and specificity of 100% and 100%, respectively. The Accelr8 Web site has a downloadable copy of the presentation at www.accelr8.com/pgen.php?pg=resources_publications.

ICAAC ( www.icaac.org) is the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Organized by the American Society for Microbiology ( www.asm.org), ICAAC is a major global congress for Clinical Microbiology and Infectious Diseases Medicine.

According to David Howson, Accelr8’s president, “We are honored by the recognition from ICAAC’s review committee. Results in our outside studies continue to strongly support the system’s accuracy and speed. The BACcel™ system continues as the only new technology to demonstrate multiple organism quantitative identification with multiple antibiotic resistance detection. The BACcel system stands alone in directly confronting the relentlessly advancing global pandemic of multiple antibiotic resistance.”

Stock quotes in this article: AXK 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs